Direct cardiovascular complications and indirect collateral damage during the COVID-19 pandemic

Burger, Achim Leo; Kaufmann, Christoph C; Jäger, Bernhard; Pogran, Edita; Ahmed, Amro; Wojta, Johann; Farhan, Serdar; Huber, Kurt

doi:10.1007/s00508-021-01956-2

Cited by 14 publications

(15 citation statements)

References 97 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our COVID-19À and COVID-19+ cohorts had a similar absolute number of all-cause deaths, consistent with the notion about indirect consequences of the pandemic, including the healthcare systems' redistributed resources toward patients with COVID-19 and the reduced standards of healthcare delivery. 28 Using a counterfactual analytical framework and conditioning for 31 covariates, we showed that all-cause death in the COVID-19+ cohort occurred 2 months sooner than if the patients did not experience SARS-CoV-2 infection. Our finding of a causal effect of either symptomatic or asymptomatic SARS-CoV-2 infection on all-cause mortality supports previous reports linking excess all-cause mortality during the pandemic with SARS-CoV-2 infection.…”

Section: Discussionmentioning

confidence: 90%

Risk of Cardiovascular Events After COVID-19

Tereshchenko¹,

Bishop²,

Fisher-Campbell³

et al. 2022

The American Journal of Cardiology

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 90%

Risk of Cardiovascular Events After COVID-19

Tereshchenko¹,

Bishop²,

Fisher-Campbell³

et al. 2022

The American Journal of Cardiology

View full text Add to dashboard Cite

“…Arterial and venous thromboembolic events are frequently observed in COVID-19 patients and contribute to increased morbidity and mortality[ 4 , 6 ].…”

Section: Thromboembolic Complicationsmentioning

confidence: 99%

“…The reported stroke rate of COVID-19 patients is approximately 1%. Notably, patients with COVID-19 seem to have an increased risk for cryptogenic and large vessel stroke[ 4 ].…”

Section: Thromboembolic Complicationsmentioning

confidence: 99%

“…The prior presence of cardiovascular disease is an important risk factor for a severe clinical course of COVID-19 and is associated with unfavorable outcomes[ 2 , 3 ]. Furthermore, COVID-19 may aggravate underlying heart disease and is frequently worsened by cardiovascular complications, such as thromboembolic events, malignant arrhythmia, and myocardial injury[ 4 ]. COVID-19 also has been associated with a direct damage of the cardiovascular system[ 5 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Cardiovascular disease and COVID-19, a deadly combination: A review about direct and indirect impact of a pandemic

Vidal-Pérez¹,

Brandão²,

Pazderník³

et al. 2022

WJCC

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID-19) is known to present with respiratory symptoms, which can lead to severe pneumonia and respiratory failure. However, it can have multisystem complications such as cardiovascular manifestations. The cardiovascular manifestations reported comprise myocarditis, cardiogenic shock, arrhythmias, pulmonary embolism, deep vein embolism, acute heart failure, and myocardial infarction. There is also an indirect impact of the pandemic on the management of cardiovascular care that has been shown clearly in multiple publications. In this review, we summarize the deadly relation of COVID-19 with cardiovascular events and the wider impact on several cardiovascular care areas by the pandemic situation

show abstract

“…In addition, the virus can adversely affect the cardiovascular system directly and indirectly. [ 3 ],[ 4 ] All these place huge demand on hospitals, especially for intensive care facilities and personnel. The unprecedented disruption in health-care system and resource allocation not only affects COVID-19 patient care, but non-COVID-19 disease care is also immensely undermined.…”

Section: Introductionmentioning

confidence: 99%

Challenges in Management of ST Elevation Myocardial Infarction during COVID-19 Pandemic

2021

View full text Add to dashboard Cite

The coronavirus disease-2019 (COVID-19) pandemic has brought unprecedented changes to our world and health-care system. Its high virulence and infectiousness directly infect people's respiratory system and indirectly disrupt our health-care infrastructure. In particular, ST elevation myocardial infarction (STEMI) is a clinical emergency emphasizes on the establishment of care system to minimize delay to reperfusion. As such, the impact of COVID-19 on STEMI care, ranging from disease severity, patient delay, diagnostic difficulty, triage to selection of reperfusion strategy and postoperative care, is immense. Importantly, not only we have to save our patients, but we must also need to protect all health-care workers and prevent environmental contamination. Otherwise, in-hospital transmission can quickly evolve into nosocomial outbreak with staff infection and quarantine which lead to health-care system collapse. In this article, we will discuss the challenges in various aspects of STEMI management during COVID-19, as well as the mitigation measures we can take to optimize outcome and our future.

show abstract

Direct cardiovascular complications and indirect collateral damage during the COVID-19 pandemic

Cited by 14 publications

References 97 publications

Risk of Cardiovascular Events After COVID-19

Risk of Cardiovascular Events After COVID-19

Cardiovascular disease and COVID-19, a deadly combination: A review about direct and indirect impact of a pandemic

Challenges in Management of ST Elevation Myocardial Infarction during COVID-19 Pandemic

Contact Info

Product

Resources

About